Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Dermatology has been at the forefront of the laser and light development which is an area in aesthetic and medical dermatology that has surged in recent years. Facial injectables are the components used for non-surgical rejuvenation procedure such as botulinum toxin (BTX) and dermal ?ller injections are now the most common aesthetic treatments performed worldwide. There are over 150 injectable ?llers on the global market, but only some of them have FDA approval. the American Society for Aesthetic Plastic Surgery revealed that despite the recession and decrease in personal ?nancial security, Americans spent approximately $10.5 billion dollars on cosmetic procedures. Men accounted for nearly 10% of the estimated 10 million procedures which provides a growth perspective for the market in the region. According to the International Society of Aesthetic Plastic Surgery there 43,100 injectables procedures done worldwide.
The global facial injectables market has gained remarkable growth due to rising demand for nonsurgical injection-based facial rejuvenation products and minimally invasive cosmetic procedures. Availability of efficient, less invasive and at lower risk injectable products coupled with changing lifestyle and growing disposable income further boost the global facial injectables market. Increase in number of aesthetic procedures driven by social media are some of the opportunities which are expected to fuel the growth of this market in coming years. However, the global facial injectables market is hampered by stringent regulatory environment and social stigma associated with cosmetic treatments.
Global facial injectables market report is segmented into product type, treatment, end users and geography.
Based on product type the global facial injectables market is segmented into botulinum toxin, hyaluronic acid, collagen and particle & polymer fillers (PPF). The collagen segment is further bifurcated into porcine/ bovine-based and human based. Similarly, particle & polymer fillers (PPF) segment is divided into, polymethylmethacrylate beads (PMMA microspheres), poly-l-lactic acid and calcium hydroxyapatite. The botulinum toxin segment held a largest share in 2018 and is expected to grow at a lucrative rate during the forecast period owing to increasing preference for combination treatments such as hyaluronic acid with botulinum toxin.
Based on treatment the global facial injectables market is categorised into wrinkle reduction, facelift, lip augmentation and others. Among various treatment, the wrinkle treatment segment held the largest share of the facial injectables market in 2017 due to growing aging population and increasing influence of social media to look younger.
The major end user of the facial injectables are hospitals, dermatology clinics, medical spas and dermatology research institutes. Among these, the medical spas segment is anticipated to grow at the highest CAGR due to growing number of medical spas in developed and developing countries. Moreover, the dermatology clinics segment accounted for the highest share in the global facial injectables market in 2018.
The global facial injectables market is studies across key regions such as North America, Europe, Asia Pacific, and Rest of the world. North America is estimated to account for the largest share in 2017, followed by Europe and Asia-Pacific. Factors such as high awareness regarding aging and increasing prevalence of skin problems are fuelling the growth of facial injectables in North America. the U.S. held the largest share of the North America facial injectables market in 2017 owing to increasing expenditure on aesthetic procedures by the consumers in the country.
The major companies operating in the global facial injectables market include Allergan Plc, Merz pharma, Galderma Laboratories, LP. (Nestle Skin Health), Anika Therapeutics, Inc, Suvena Medical Inc, Prollenium Medical Technologies, Bloomage Biotechnology Corporation Limited, Sinclair Pharma, Teoxane, etc. Bloomage BioTechnology Corporation Limited, Teoxane among others. Market players are involved in product launches and collaboration agreements to exploit maximum revenue potential in global facial injectables market. Merz, a global leader in medical aesthetics, in 2018, announced the launch of Belotero Lips, with products specifically designed for lip enhancement and treatment of perioral lines. The line includes two hyaluronic acid (HA) dermal filler products that complement each other to deliver safe, effective and natural-looking cosmetic results.
Facial injectables used aesthetically to reduce the effects of aging and to de-emphasize previous scars. The global facial injectables market has gained remarkable growth due to rising demand for nonsurgical injection-based facial rejuvenation products and minimally invasive cosmetic procedures. Subcutaneous augmentation in appropriate areas with injectable fillers replaces this lost tissue, producing a rejuvenating effect. Fillers can work synergistically with surgical procedure to improve results. Moreover, facial fillers are most useful in the lower third of the face. Based on product type the global facial injectables market is segmented into botulinum toxin, hyaluronic acid, collagen and particle & polymer fillers (PPF). The collagen segment is further bifurcated into porcine/ bovine-based and human based. Similarly, particle & polymer fillers (PPF) segment is divided into, polymethylmethacrylate beads (PMMA microspheres), poly-l-lactic acid and calcium hydroxyapatite. Based on treatment, the global facial injectables market is categorised into wrinkle treatment, facelift, lip augmentation and others. The major end user of the facial injectables are hospitals, dermatology clinics, medical spas and dermatology research institutes. The global facial injectables market is studies across key regions such as North America, Europe, Asia Pacific, and Rest of the world. North America is estimated to account for the largest share in 2017, followed by Europe and Asia-Pacific. Factors such as high awareness regarding aging and increasing prevalence of skin problems are fuelling the growth of facial injectables in North America. Some of the major players operating in the facial injectables market include Allergan Plc, Merz pharma, Galderma Laboratories, LP. (Nestle Skin Health), Anika Therapeutics, Inc, Suvena Medical Inc, Prollenium Medical Technologies, Bloomage Biotechnology Corporation Limited, Teoxane, etc. Bloomage BioTechnology Corporation Limited, Sinclair Pharma, Teoxane among others.
Why to buy this report:
